NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Stock data | 2023 | Change |
---|---|---|
Price | $0.01 | N/A |
Market Cap | $239.56K | N/A |
Shares Outstanding | 23.96M | 44.96% |
Employees | 2.00 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $0 | N/A |
Earnings | -$4.72M | N/A |